TipRanks
Go Ultimate55% OFF

Corteva (2X0) Q2 2026 Earnings Report

CH:2X0 Q2 2026 EPS Results

Actual EPS
CHF 0.28
Consensus EPS
CHF 0.28
Beat/Miss
Beat by +CHF 0.01
One Year Ago EPS
CHF 0.27

CH:2X0 Q2 2026 Revenue Results

Actual Revenue
CHF 5.26B
Expected Revenue
CHF 5.44B
Beat/Miss
Missed by -CHF 181.74M
YoY Revenue Growth
-1.19%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
After Close
Conference Call
Thursday, July 30, 2026
CH:2X0 Upcoming Earnings

Corteva's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CH:2X0 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 30, 2026|% Change Since:―|
Earnings Call Sentiment|Positive

The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.

Company Guidance

Corteva raised full‑year 2026 guidance, now expecting operating EBITDA of $4.1–$4.3 billion and operating EPS of $3.60–$3.80 (midpoints imply ~9% EBITDA growth and ~11% EPS growth versus last year) with an operating EBITDA margin target of 22.5%–23.5%; that outlook is supported by a strong first half (net sales $11.3B, +4% YoY, organic +2%; Q2 net sales $6.4B), first‑half operating EBITDA $3.7B (+10%), operating EPS +14%, and margin expansion of nearly 200 basis points to ~32.8%. Management assumes seed organic growth of low‑single digits, crop protection volumes up high‑single digits (driven by new products) with pricing down low‑ to mid‑single digits, Brazil corn area ~flat, and typical seasonality (a Q3 operating EBITDA loss similar to 2024 with most second‑half earnings in Q4); year‑to‑date drivers include >$160M of cost/productivity savings, ~$90M improvement in net royalties, and an ~$85M favorable currency impact, and absent one‑time items they expect free cash flow conversion in line with prior midterm targets.

  • Raised Full-Year GuidanceOperating EBITDA guidance increased to $4.1B–$4.3B and operating EPS to $3.60–$3.80. At the midpoint this implies ~9% EBITDA growth and ~11% EPS growth versus prior year.
  • First Half Revenue and EBITDA GrowthFirst half net sales rose 4% to $11.3B (organic sales +2%). First half operating EBITDA increased 10% to $3.7B, driven by strong commercial execution across seed and crop protection.
  • Margin Expansion and EPSOperating margins expanded (nearly 200 bps of margin improvement referenced; margin reported at 32.8% in the first half). Operating EPS increased 14% in the first half.
  • Strong Seed Performance and Licensing MomentumOrganic seed sales improved across all regions (led by North America and EMEA). Net royalties improved by ~$90M and the licensing business is several years ahead of plan, with licensing contributing materially to pricing/mix.
  • Crop Protection New-Product MomentumNew crop protection products are a growing engine (~$2B of revenue expected this year from new products) with volumes up (high single-digit growth in new products) and pricing essentially flat in the first half for new introductions.
  • Productivity, Cost and Currency BenefitsCost and productivity improvements contributed >$160M to EBITDA; price & mix added ~ $100M; volume contributed ~ $40M; currency contributed ~ $85M — collectively driving ~ $350M year-over-year EBITDA improvement in H1.
  • Separation Progress and Lower-than-Expected Dis-synergiesSeparation (targeting Oct 1) on track with Form 10 filed, leadership and boards appointed, investor day planned. Run-rate dis-synergies largely offset; timing-related headwind this year reduced to ~ $25M (better than earlier estimates).
  • Long-Term R&D and Capital ReturnsSince 2019 the company invested nearly $9B in R&D, improved operating EBITDA by $1.7B and expanded margins by ~750 bps, while returning nearly $8B of cash to shareholders — supporting long-term value creation.

CH:2X0 Earnings History

CH:2X0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 11, 20262026 (Q3)0.01--0.03――
Jul 30, 20262026 (Q2)0.280.280.274.55% (+0.01)
May 05, 20262026 (Q1)0.150.190.1432.35% (+0.05)
Feb 03, 20262025 (Q4)0.030.030.04-31.25% (-0.01)
Nov 04, 20252025 (Q3)-0.06-0.03-0.0652.70% (+0.03)
Aug 06, 20252025 (Q2)0.230.270.2320.00% (+0.05)
May 07, 20252025 (Q1)0.110.140.1126.87% (+0.03)
Feb 05, 20252024 (Q4)0.040.040.02108.70% (+0.02)
Nov 06, 20242024 (Q3)-0.04-0.06-0.03-111.43% (-0.03)
Jul 31, 20242024 (Q2)0.210.230.214.58% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More